Showing results (211-220 of 279) with videos related to
Sort By:
Pageof 28
British Journal of Cancer|November 25, 2010
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumabA Gualberto, M L Hixon, D D Karp, et al.Cancer Causes & Control : CCC|November 10, 2012
Racial variation in vitamin D cord blood concentration in white and black male neonatesMonika Eichholzer, Elizabeth A Platz, Jessica L Bienstock, et al.The Journal of the American Academy of Orthopaedic Surgeons|August 7, 2012
Special topicsRomney C Andersen, Scott B Shawen, John F Kragh, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.Journal of Orthopaedic Trauma|June 20, 2020
Quantitative Lesser Trochanter Profile Versus Cortical Step Sign in Assessing Femoral Malrotation After Femoral NailingJonathan Klaucke, Nathan N O'Hara, David Peterson, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2009
Insulin-like growth factors and leukocyte telomere length: the cardiovascular health studyRobert C Kaplan, Annette L Fitzpatrick, Michael N Pollak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancerW D Foulkes, N Wong, J S Brunet, et al.Mechanisms of Ageing and Development|November 17, 2009
Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjectsMichelangela Barbieri, Giuseppe Paolisso, Masayuki Kimura, et al.British Journal of Cancer|May 30, 2007
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohortsB M Wolpin, D S Michaud, E L Giovannucci, et al.Geroscience|August 29, 2018
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers WorkgroupJamie N Justice, Luigi Ferrucci, Anne B Newman, et al.Pageof 28